NAFLD subjects had significantly higher BMI, WC, Waist-to-Hip ratio (WHR), blood pressure levels, urea, AST, ALT, fasting blood glucose levels, HOMA-IR, TC, TG, LDL-C, γ-GGT, ALP, and ferritin levels, as well as significantly lower HDL-C levels, compared with normal controls. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.